Management of the behavioral and psychological symptoms of dementia

Elizabeth C Hersch, Sharon FalzgrafVA Puget Sound Health Care System, Tacoma, Washington, USAAbstract: More than 50% of people with dementia experience behavioral and psychological symptoms of dementia (BPSD). BPSD are distressing for patients and their caregivers, and are often the reason for place...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Elizabeth C Hersch, Sharon Falzgraf
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2008
Materias:	Geriatrics RC952-954.6
Acceso en línea:	https://doaj.org/article/35c46f50525b41e8a9fe9ad4432d9055
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:35c46f50525b41e8a9fe9ad4432d9055
record_format	dspace
spelling	oai:doaj.org-article:35c46f50525b41e8a9fe9ad4432d90552021-12-02T02:34:57ZManagement of the behavioral and psychological symptoms of dementia1178-1998https://doaj.org/article/35c46f50525b41e8a9fe9ad4432d90552008-01-01T00:00:00Zhttps://www.dovepress.com/management-of-the-behavioral-and-psychological-symptoms-of-dementia-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Elizabeth C Hersch, Sharon FalzgrafVA Puget Sound Health Care System, Tacoma, Washington, USAAbstract: More than 50% of people with dementia experience behavioral and psychological symptoms of dementia (BPSD). BPSD are distressing for patients and their caregivers, and are often the reason for placement into residential care. The development of BPSD is associated with a more rapid rate of cognitive decline, greater impairment in activities of daily living, and diminished quality of life (QOL). Evaluation of BPSD includes a thorough diagnostic investigation, consideration of the etiology of the dementia, and the exclusion of other causes, such as drug-induced delirium, pain, or infection. Care of patients with BPSD involves psychosocial treatments for both the patient and family. BPSD may respond to those environmental and psychosocial interventions, however, drug therapy is often required for more severe presentations. There are multiple classes of drugs used for BPSD, including antipsychotics, anticonvulsants, antidepressants, anxiolytics, cholinesterase inhibitors and NMDA modulators, but the evidence base for pharmacological management is poor, there is no clear standard of care, and treatment is often based on local pharmacotherapy customs. Clinicians should discuss the potential risks and benefits of treatment with patients and their surrogate decision makers, and must ensure a balance between side effects and tolerability compared with clinical benefit and QOL.Keywords: dementia, management, behavioral symptoms, psychological symptomsElizabeth C HerschSharon FalzgrafDove Medical PressarticleGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 2, Pp 611-621 (2008)
institution	DOAJ
collection	DOAJ
language	EN
topic	Geriatrics RC952-954.6
spellingShingle	Geriatrics RC952-954.6 Elizabeth C Hersch Sharon Falzgraf Management of the behavioral and psychological symptoms of dementia
description	Elizabeth C Hersch, Sharon FalzgrafVA Puget Sound Health Care System, Tacoma, Washington, USAAbstract: More than 50% of people with dementia experience behavioral and psychological symptoms of dementia (BPSD). BPSD are distressing for patients and their caregivers, and are often the reason for placement into residential care. The development of BPSD is associated with a more rapid rate of cognitive decline, greater impairment in activities of daily living, and diminished quality of life (QOL). Evaluation of BPSD includes a thorough diagnostic investigation, consideration of the etiology of the dementia, and the exclusion of other causes, such as drug-induced delirium, pain, or infection. Care of patients with BPSD involves psychosocial treatments for both the patient and family. BPSD may respond to those environmental and psychosocial interventions, however, drug therapy is often required for more severe presentations. There are multiple classes of drugs used for BPSD, including antipsychotics, anticonvulsants, antidepressants, anxiolytics, cholinesterase inhibitors and NMDA modulators, but the evidence base for pharmacological management is poor, there is no clear standard of care, and treatment is often based on local pharmacotherapy customs. Clinicians should discuss the potential risks and benefits of treatment with patients and their surrogate decision makers, and must ensure a balance between side effects and tolerability compared with clinical benefit and QOL.Keywords: dementia, management, behavioral symptoms, psychological symptoms
format	article
author	Elizabeth C Hersch Sharon Falzgraf
author_facet	Elizabeth C Hersch Sharon Falzgraf
author_sort	Elizabeth C Hersch
title	Management of the behavioral and psychological symptoms of dementia
title_short	Management of the behavioral and psychological symptoms of dementia
title_full	Management of the behavioral and psychological symptoms of dementia
title_fullStr	Management of the behavioral and psychological symptoms of dementia
title_full_unstemmed	Management of the behavioral and psychological symptoms of dementia
title_sort	management of the behavioral and psychological symptoms of dementia
publisher	Dove Medical Press
publishDate	2008
url	https://doaj.org/article/35c46f50525b41e8a9fe9ad4432d9055
work_keys_str_mv	AT elizabethchersch managementofthebehavioralandpsychologicalsymptomsofdementia AT sharonfalzgraf managementofthebehavioralandpsychologicalsymptomsofdementia
_version_	1718402341734973440

Management of the behavioral and psychological symptoms of dementia

Ejemplares similares